Toggle Contrast

Category: News


AI helping GPs identify possible cancers earlier

RM Partners has just launched a pilot in Sutton that uses an award winning AI decision support tool, C the Signs, to help GPs identify patients at...
Read full story

New patient information leaflet on biosimilar trastuzumab

The second cancer biosimilar, trastuzumab, has been approved to treat patients with HER2-positive early breast cancer, metastatic breast cancer, and...
Read full story

Learning how to use new RAPID technology

This system is one element of the new RAPID (Rapid Assessment Prostate Imaging and Diagnosis) pathway, and enables clinicians to accurately take...
Read full story

Pan London Cancer Research Fellowships Available for 2018/19

We are offering exciting opportunities for medical and non-medical research fellows to undertake a research project. This has London-based support...
Read full story

Launching our new model pathway groups

RM Partners is holding a series of events in May to introduce healthcare professionals to the new operating model for six of our tumour-specific...
Read full story

Recruiting for Digital Solutions Clinical Lead

RM Partners are offering an exciting opportunity for the appointment of a clinical lead to provide strategic and subject matter expert input into the...
Read full story

Our RAPID prostate pilot makes front page news

The Daily Mail, along with The Times, the BBC and other news outlets, recently featured our new RAPID prostate cancer pathway that we are piloting at...
Read full story

Improving cancer screening uptake in marginalised groups in Kingston

RM Partners is working alongside Kingston Council’s Public Health Department to increase participation in national cancer screening programmes...
Read full story

Recruitment open for new pathway group chair

RM Partners runs a number of pathway groups assembled from healthcare professionals across west London that meet to share experience, best practice...
Read full story

Piloting a new streamlined pathway for prostate cancer

RM Partners is piloting a new prostate cancer pathway at three hospitals across west London – Charing Cross Hospital, Epsom Hospital and St...
Read full story